Tenaya Therapeutics, Inc. Common Stock

TNYANASDAQ • USD
ThemeGenomics & Precision Med.›Gene Therapy & Gene Editing
0.73 USD
↘ 0.04 (5.70%)AT CLOSE (11:59 AM EDT)
0.74
↗ 0.02 (2.18%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
0.74
↗ 0.02 (2.18%)
🔴Market: CLOSED
Open?$0.76
High?$0.76
Low?$0.71
Prev. Close?$0.77
Volume?4.5M
Avg. Volume?4.7M
VWAP?$0.73
Rel. Volume?0.97x
Bid / Ask
Bid?$0.62 × 100
Ask?$0.84 × 100
Spread?$0.22
Midpoint?$0.73
Valuation & Ratios
Market Cap?158.4M
Shares Out?217.0M
Float?155.9M
Float %?71.9%
P/E Ratio?N/A
P/B Ratio?1.49
EPS?-$0.38
Dividend?0.00%
Ex-Dividend?N/A

Tenaya Therapeutics, Inc. Common Stock (TNYA) trades at $0.73 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. TNYA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
Themes
Healthcare - Genomics & Precision Medicine›Gene Therapy & Gene EditingBiotech - Drug Development›Rare Disease Therapeutics
Employees
70
Market Cap
158.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.tenayatherapeutics.com
Listed
2021-07-30
Address
171 OYSTER POINT BLVD., SUITE 500
SOUTH SAN FRANCISCO, CA 94080
Phone: 415-865-2066
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
77
Short Sent.?
31
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.57Distress
Confidence?41%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?18.44%High
Short Interest?28.8M
Days to Cover?4.4
Free Float155.9M
Avg Daily Volume6.5M
Settlement Date2026-05-15
Financial Health
Current Ratio?5.75Strong
Quick Ratio?5.75Strong
Cash Ratio?4.82Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
87
1.49CHEAP▾
P/S?
Peers
100
S&P
3
704.04HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.0CHEAP▾
EV/Sales?
Peers
100
S&P
3
344.54HIGH▾
Returns & Efficiency
ROE?
S&P
3
-78.2%WEAK▾
ROA?
S&P
3
-61.5%WEAK▾
Cash Flow & Enterprise
FCF?$-64632000
Enterprise Value?$77.5M
Fundamentals ratios updated end of day
MarketsMoversWatchlist